Can texts and calls help taxi drivers shed pounds?

NCT ID NCT05770570

Recruiting now Disease control Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study aims to help overweight or obese taxi and ride-share drivers lose weight through a combination of counseling, text messages, phone support, and self-monitoring tools. Researchers will enroll about 1,785 drivers in New York City to find out which parts of the program work best and are most cost-effective. The goal is to create a program that can be widely used to improve health in this hard-to-reach group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: diet and physical activity counseling, text messages, phone calls, and self-monitoring tools
What this could lead to: If successful, this could provide a cost-effective, scalable weight-loss program tailored for taxi and ride-share drivers, helping reduce obesity in this hard-to-reach group.
What could go wrong: This is a Phase 2 trial testing multiple components, so it is still early. The program may not lead to significant weight loss for all participants, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESE OBESITY OVERWEIGHT OVERWEIGHT AND OBESITY OVERWEIGHT OR OBESITY

Contacts and locations

Locations

Mexican Consulate's Ventanilla de Salud (VDS)
RECRUITING

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.